Neurobiological Technologies Inc (NASDAQ:NTII) has filed its 10Q for the period ended march 31, 2009. After reviewing the 10Q, we have reduced our estimate of NTII’s liquidation value to $19.6M or $0.73 per share. NTII closed on Friday at $0.72, which is approximately our estimate of its value, and so we are taking the opportunity [...]
Posts Tagged ‘Neurobiological Technologies Inc (NASDAQ:NTII)’
Neurobiological Technologies Inc (NASDAQ:NTII) 10Q update; Greenbackd exits
Posted in Activist Investors, Biotechnology Value Fund, Neurobiological Technologies Inc (NASDAQ:NTII), Stocks, tagged Activist investment, Biotechnology Value Fund, Liquidating Value, Liquidation Value, Net Cash Stock, Neurobiological Technologies Inc (NASDAQ:NTII) on May 11, 2009 | 2 Comments »
NTII on the block; engages financial adviser
Posted in Activist Investors, Biotechnology Value Fund, Neurobiological Technologies Inc (NASDAQ:NTII), Stocks, tagged Activist investment, Biotechnology Value Fund, Liquidating Value, Neurobiological Technologies Inc (NASDAQ:NTII) on March 31, 2009 | Leave a Comment »
Neurobiological Technologies Inc (NASDAQ:NTII) has engaged a financial adviser to explore a sale of the company or its major assets to determine “if there is a transaction more beneficial to our shareholders than a liquidation,” according to its CEO, William Fletcher. We’ve been following NTII (see our post archive here) because it’s trading at a [...]
NYTimes says investors want biotech firms to cash out
Posted in Activist Investors, Avigen (NASDAQ:AVGN), Biotechnology Value Fund, Neurobiological Technologies Inc (NASDAQ:NTII), Northstar Neuroscience Inc (NASDAQ:NSTR), Stocks, tagged Activist investment, Avigen Inc (NASDAQ:AVGN), Biotechnology Value Fund, Neurobiological Technologies Inc (NASDAQ:NTII), Northstar Neuroscience Inc (NASDAQ:NSTR), RA Capital Management on March 11, 2009 | Leave a Comment »
The New York Times has an article by Andrew Pollack, “Drug Investors Lose Patience,” about investors pushing biotechnology companies to liquidate and return capital to investors. Pollack notes that such clashes have become much more common in recent months as the stock market crash has pushed the market capitalization of many biotechnology companies to less [...]
Neurobiological Technologies Inc (NASDAQ:NTII)
Posted in Activist Investors, Biotechnology Value Fund, Highland Capital Management, Millennium Technology Value Partners, Net Cash Stocks, Neurobiological Technologies Inc (NASDAQ:NTII), Stocks, tagged Activist investment, Biotechnology Value Fund, Highland Capital Management, Liquidating Value, Millennium Technology Value Partners, Net Cash Stock, Neurobiological Technologies Inc (NASDAQ:NTII) on February 23, 2009 | 5 Comments »
Neurobiological Technologies Inc (NASDAQ:NTII) is a particularly interesting play. Prima facie, it appears to be a cash-burning biotechnology stock trading at a premium to its liquidating value. In other words, a stock we wouldn’t touch with a ten foot pole. On closer inspection, however, it becomes clear that NTII is trading at its net cash [...]

